Capital Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-89,680
| Closed | -$18.1M | – | 188 |
|
|
2021
Q2 | $18.1M | Buy |
89,680
+1,033
| +1% | +$208K | 0.21% | 104 |
|
|
2021
Q1 | $19M | Buy |
88,647
+1,716
| +2% | +$369K | 0.23% | 104 |
|
|
2020
Q4 | $20.5M | Sell |
86,931
-34,969
| -29% | -$8.26M | 0.25% | 96 |
|
|
2020
Q3 | $33.2M | Buy |
121,900
+1,114
| +0.9% | +$303K | 0.45% | 67 |
|
|
2020
Q2 | $35.1M | Buy |
120,786
+330
| +0.3% | +$95.8K | 0.51% | 56 |
|
|
2020
Q1 | $28.7M | Buy |
120,456
+11,685
| +11% | +$2.78M | 0.48% | 58 |
|
|
2019
Q4 | $23.8M | Buy |
108,771
+108,521
| +43,408% | +$23.8M | 0.31% | 83 |
|
|
2019
Q3 | $42K | Sell |
250
-18
| -7% | -$3.02K | ﹤0.01% | 451 |
|
|
2019
Q2 | $49K | Buy |
268
+7
| +3% | +$1.28K | ﹤0.01% | 429 |
|
|
2019
Q1 | $48K | Sell |
261
-108
| -29% | -$19.9K | ﹤0.01% | 409 |
|
|
2018
Q4 | $61K | Buy |
369
+203
| +122% | +$33.6K | ﹤0.01% | 396 |
|
|
2018
Q3 | $32K | Buy |
166
+115
| +225% | +$22.2K | ﹤0.01% | 519 |
|
|
2018
Q2 | $9K | Hold |
51
| – | – | ﹤0.01% | 545 |
|
|
2018
Q1 | $8K | Hold |
51
| – | – | ﹤0.01% | 538 |
|
|
2017
Q4 | $8K | Buy |
+51
| New | +$8K | ﹤0.01% | 570 |
|